Search

everythinglearnresearchcommunity

for

Search:↓

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Some early COVID-19 mutations in patients predicted future common virus mutations.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Sex hormones may affect COVID-19 severity and outcomes.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Teledermatology effectively managed most skin conditions remotely during the COVID-19 pandemic.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Androgens might play a role in the severity of COVID-19.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

COVID-19 can cause temporary hair loss.

The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.